SILK Silk Road Medical Inc

Price (delayed)

$27.09

Market cap

$1.07B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.38

Enterprise value

$1.12B

Silk Road Medical, Inc.,is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company's flagship procedure, TransCarotid ...

Highlights
The gross profit is up by 25% year-on-year and by 7% since the previous quarter
SILK's revenue is up by 23% YoY and by 4.7% QoQ
The company's quick ratio rose by 40% QoQ but it fell by 6% YoY
Silk Road Medical's equity has decreased by 7% YoY and by 2.6% QoQ

Key stats

What are the main financial stats of SILK
Market
Shares outstanding
39.44M
Market cap
$1.07B
Enterprise value
$1.12B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
7.21
Price to sales (P/S)
5.73
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.05
Earnings
Revenue
$185.49M
EBIT
-$46.77M
EBITDA
-$43.03M
Free cash flow
-$36.8M
Per share
EPS
-$1.38
Free cash flow per share
-$0.94
Book value per share
$3.76
Revenue per share
$4.72
TBVPS
$6.43
Balance sheet
Total assets
$252.31M
Total liabilities
$105.03M
Debt
$75.89M
Equity
$147.29M
Working capital
$214.36M
Liquidity
Debt to equity
0.52
Current ratio
11.05
Quick ratio
9.45
Net debt/EBITDA
-1.24
Margins
EBITDA margin
-23.2%
Gross margin
73.3%
Net margin
-28.9%
Operating margin
-30.9%
Efficiency
Return on assets
-20.6%
Return on equity
-35.4%
Return on invested capital
-16.4%
Return on capital employed
-20.2%
Return on sales
-25.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SILK stock price

How has the Silk Road Medical stock price performed over time
Intraday
0.11%
1 week
0.18%
1 month
21.15%
1 year
16.17%
YTD
120.78%
QTD
0.18%

Financial performance

How have Silk Road Medical's revenue and profit performed over time
Revenue
$185.49M
Gross profit
$135.98M
Operating income
-$57.29M
Net income
-$53.67M
Gross margin
73.3%
Net margin
-28.9%
The gross profit is up by 25% year-on-year and by 7% since the previous quarter
SILK's revenue is up by 23% YoY and by 4.7% QoQ
The net margin has grown by 20% year-on-year and by 8% since the previous quarter
The operating margin has grown by 12% YoY and by 8% from the previous quarter

Growth

What is Silk Road Medical's growth rate over time

Valuation

What is Silk Road Medical stock price valuation
P/E
N/A
P/B
7.21
P/S
5.73
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.05
Silk Road Medical's EPS has increased by 7% YoY and by 4.2% QoQ
The P/B is 51% below the 5-year quarterly average of 14.8 but 44% above the last 4 quarters average of 5.0
Silk Road Medical's equity has decreased by 7% YoY and by 2.6% QoQ
The stock's price to sales (P/S) is 61% less than its 5-year quarterly average of 14.7 but 30% more than its last 4 quarters average of 4.4
SILK's revenue is up by 23% YoY and by 4.7% QoQ

Efficiency

How efficient is Silk Road Medical business performance
The return on invested capital rose by 31% year-on-year and by 6% since the previous quarter
The company's return on equity rose by 29% YoY
Silk Road Medical's return on sales has increased by 22% YoY and by 9% QoQ
The ROA has grown by 20% YoY and by 3.3% from the previous quarter

Dividends

What is SILK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SILK.

Financial health

How did Silk Road Medical financials performed over time
The total assets is 140% greater than the total liabilities
The company's quick ratio rose by 40% QoQ but it fell by 6% YoY
The current ratio has grown by 39% from the previous quarter
The debt is 48% smaller than the equity
The company's debt to equity rose by 11% YoY and by 4% QoQ
Silk Road Medical's equity has decreased by 7% YoY and by 2.6% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.